Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report

Abstract Background Immune checkpoint inhibitors (ICIs) are crucial in cancer treatment; however, they carry the risk of immune-related adverse events (irAEs), such as enteritis. Case presentation: This study investigated the role of the gut microbiota during the onset and remission of irAE enteriti...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Gut Pathogens
المؤلفون الرئيسيون:	Yuki Hirata, Yoshiki Tanaka, Haruka Yokota, Hiroshi Ohno, Koji Nishida, Hikaru Shimizu, Noboru Mizuta, Kei Nakazawa, Ryoji Koshiba, Kazuki Kakimoto, Takako Miyazaki, Shiro Nakamura, Hiroki Nishikawa
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2024-07-01
الموضوعات:	Immune-related adverse events Enteritis Microbiota Immune checkpoint inhibitors
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13099-024-00630-y